Kambiz Yazdi
Stock Analyst at BTIG
(4.47)
# 269
Out of 5,161 analysts
20
Total ratings
65%
Success rate
24.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintains: Buy | $47 → $53 | $28.69 | +84.73% | 3 | Mar 11, 2026 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $49 | $34.07 | +43.82% | 3 | Mar 11, 2026 | |
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $36.62 | +58.38% | 4 | Mar 2, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $507 → $843 | $303.37 | +177.88% | 5 | Dec 29, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $16.71 | +37.64% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $22.90 | -17.03% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $14.06 | +6.72% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.57 | +217.66% | 1 | Apr 12, 2024 |
Rapport Therapeutics
Mar 11, 2026
Maintains: Buy
Price Target: $47 → $53
Current: $28.69
Upside: +84.73%
vTv Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $49
Current: $34.07
Upside: +43.82%
Sionna Therapeutics
Mar 2, 2026
Reiterates: Buy
Price Target: $58
Current: $36.62
Upside: +58.38%
Praxis Precision Medicines
Dec 29, 2025
Maintains: Buy
Price Target: $507 → $843
Current: $303.37
Upside: +177.88%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $16.71
Upside: +37.64%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $22.90
Upside: -17.03%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $14.06
Upside: +6.72%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.57
Upside: +217.66%